The brakes of inflammation

February 27, 2013 by Angela Herring
Professor Michail Sitkovsky’s work on adenosine receptors has spurred a body of research recently reviewed in the New England Journal of Medicine. Credit: Brooks Canaday

In the last few decades, sci­en­tists have come to attribute an immuno­log­ical expla­na­tion to many can­cers. It is now thought that tumors rise up rou­tinely in the body but that a healthy immune system blocks their devel­op­ment. Thus, for patients who do develop cancer, the immune system is par­tially to blame.

Treat­ment has there­fore come to involve immunotherapy, in which clin­i­cians stim­u­late a patient's immune system with cancer vac­cines. The immune system responds by cre­ating T-​​cells whose job is to kill the .

"But immunotherapy of cancer doesn't live up to expec­ta­tions," according to North­eastern pro­fessor Michail Sitkovsky, adding that T-​​cells induced by cancer vac­cines simply don't kill tumor cellss inside the body, though they do so quite well in a .

"The were alert and eager to kill the tumor, but the tumor man­aged to put the killer to sleep," said Sitkovsky, the Eleanor W. Black Chair and Pro­fessor of Immuno­phys­i­ology and Phar­ma­ceu­tical Biotech­nology and founding director of Northeastern's New Eng­land Inflam­ma­tion and Tissue Pro­tec­tion Insti­tute. "This is what hap­pens in a majority of cancers."

But what, Sitkovsky wanted to know, puts the killer cells to sleep?

His desire to find out spurred him and his research team to dis­cover a sig­naling pathway that he calls "the brakes of the immune system," which was reported in 2001 in the journal Nature. In the last sev­eral years, many researchers have fol­lowed up on Sitkovsky's work, impli­cating the pathway in a variety of inflam­ma­tory dis­eases. In a recent article in the esteemed New Eng­land Journal of Med­i­cine, he and his col­leagues at the Uni­ver­sity of Col­orado School of Med­i­cine and Har­vard Med­ical School reviewed the body of work that has emerged since Sitkovsky's discovery.

The find­ings indi­cated that, during inflam­ma­tion, mol­e­cules called "purines" are released from cells and act as phys­i­o­log­ical brake pedals by inhibiting an immune response. "This is how the immune system works," said Sitkovsky. "It is acti­vated to kill pathogens, but it also has brakes because the immune system does a lot of col­lat­eral damage to inno­cent bystanders."

The most impor­tant among these bystanders are the cells lining our blood ves­sels. "Because of damage to blood ves­sels, there is inter­rup­tion of blood supply," Sitkovsky explained. "No blood supply: no oxygen supply." This lack of oxygen is called hypoxia, which trig­gers the release of a purine mol­e­cule called adeno­sine. When adeno­sine binds to recep­tors on the sur­face of T-​​cells, they stop their killing spree, acting as the 's brake pedal.

And here's the clincher: Tumors, which grow so quickly that blood ves­sels can't keep up with them, have evolved to per­se­vere in the absence of oxygen and are inher­ently hypoxic. As a result, they are rid­dled with adenosine.

"So killers come"—here Sitkovsky grasped his throat and pre­tended to asphyxiate—"and then run away!"

To forcibly restore T-​​cells' immuno­log­ical func­tion, he and his team of researchers looked for a drug that would block the effects of adeno­sine. In a great stroke of luck, it turned out that the most widely used and easily accessed psy­choac­tive drug in the world—caffeine—does just that.

Sitkovsky looked to epi­demi­ology for evi­dence of a cor­re­la­tion between coffee drinkers and tumor sup­pres­sion and found that dozens of studies with hun­dreds of thou­sands of par­tic­i­pants showed that coffee seemed to have a cancer-​​preventive effect in women. The pat­tern wasn't as strong among males, because testos­terone, like adeno­sine, is another immunosuppressant.

The team's pre­clin­ical studies using high doses of caf­feine to block adeno­sine resulted in tumor rejec­tion and mouse sur­vival. The results were reported in the Pro­ceed­ings of the National Academy of Sci­ences in 2006 and the approach is now being tested in human clin­ical trials in con­junc­tion with tra­di­tional cancer techniques.

Explore further: From protein signaling to cancer drug development

Related Stories

From protein signaling to cancer drug development

January 8, 2013
(Medical Xpress)—Living organ­isms depend on pro­teins for their sur­vival. These large, com­plex mol­e­cules mediate nearly every life func­tion, but when the genes that code for them start to mutate, those func­tions ...

The language of neural cells

August 23, 2012
Imagine if we could under­stand the lan­guage two neu­rons use to com­mu­ni­cate. We might learn some­thing about how thoughts and con­scious­ness are formed. At the very least, our improved under­standing of neuron ...

Validation for flu prediction

January 8, 2013
(Medical Xpress)—In 2009, the H1N1 virus slipped into the blood­streams of more than 40 mil­lion people around the world. In just four months, it killed more than 14,000 indi­vid­uals as it trav­eled from Mexico to ...

Tracking America's physical activity, via smartphone

June 19, 2012
“We know that most Amer­i­cans are too seden­tary,” said North­eastern asso­ciate pro­fessor Stephen Intille, a founding fac­ulty member of the university’s new Per­sonal ...

Complex systems made simple

February 18, 2013
Just as the name implies, complex systems are difficult to tease apart. An organism's genome, a bio­chem­ical reac­tion, or even a social network all contain many interdependent components—and changing any one of them ...

Professor works toward a better brainwave monitor

December 6, 2012
The elec­trical out­puts of the brain con­tain mas­sive amounts of infor­ma­tion that could be a pow­erful resource if we could fully tap into it. Our brain processes things we see before any con­scious recog­ni­tion ...

Recommended for you

Immune system can be modulated by targeted manipulation of cell metabolism

August 21, 2017
In its attempt to fight a serious bacterial infection, caused by listeria, for example, the immune system can become so over-activated that the resulting inflammatory response and its consequences can quickly lead to death. ...

Australian researchers in peanut allergy breakthrough

August 17, 2017
Australian researchers have reported a major breakthrough in the relief of deadly peanut allergy with the discovery of a long-lasting treatment they say offers hope that a cure will soon be possible.

Genetic variants found to play key role in human immune system

August 16, 2017
It is widely recognized that people respond differently to infections. This can partially be explained by genetics, shows a new study published today in Nature Communications by an international collaboration of researchers ...

Study identifies a new way to prevent a deadly fungal infection spreading to the brain

August 16, 2017
Research led by the University of Birmingham has discovered a way to stop a deadly fungus from 'hijacking' the body's immune system and spreading to the brain.

Biophysics explains how immune cells kill bacteria

August 16, 2017
(Tokyo, August 16) A new data analysis technique, moving subtrajectory analysis, designed by researchers at Tokyo Institute of Technology, defines the dynamics and kinetics of key molecules in the immune response to an infection. ...

How a nutrient, glutamine, can control gene programs in cells

August 15, 2017
The 200 different types of cells in the body all start with the same DNA genome. To differentiate into families of bone cells, muscle cells, blood cells, neurons and the rest, differing gene programs have to be turned on ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Anthony1888
not rated yet Feb 27, 2013
this is true. everyone has cancer. my mother just recently got cancer and instead of radiation she went to a homiopathic doctor and boosted her immune system of what it needed and shes cured. this is old news. maybe now it will be popular because of this "new discovery..."
tekram
not rated yet Feb 27, 2013
Holger K. Eltzschig, Michail V. Sitkovsky, Simon C. Robson. Purinergic Signaling during Inflammation. New England Journal of Medicine, 2012; 367 (24): 2322 DOI: 10.1056/NEJMra1205750

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.